WO1992010221A3 - Systeme et procede d'oxygenation du c×ur utilisant des liquides sous-pericardiques - Google Patents

Systeme et procede d'oxygenation du c×ur utilisant des liquides sous-pericardiques Download PDF

Info

Publication number
WO1992010221A3
WO1992010221A3 PCT/US1991/009349 US9109349W WO9210221A3 WO 1992010221 A3 WO1992010221 A3 WO 1992010221A3 US 9109349 W US9109349 W US 9109349W WO 9210221 A3 WO9210221 A3 WO 9210221A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxygenation
heart
present
solutions
subpericardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1991/009349
Other languages
English (en)
Other versions
WO1992010221A2 (fr
Inventor
Donald R Vanderipe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/627,178 external-priority patent/US5213570A/en
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Priority to EP92903781A priority Critical patent/EP0515676B1/fr
Priority to DE69125152T priority patent/DE69125152T2/de
Priority to CA002076009A priority patent/CA2076009C/fr
Publication of WO1992010221A2 publication Critical patent/WO1992010221A2/fr
Publication of WO1992010221A3 publication Critical patent/WO1992010221A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71—Suction drainage systems
    • A61M1/77—Suction-irrigation systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84—Drainage tubes; Aspiration tips
    • A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M2025/0001—Catheters; Hollow probes for pressure measurement
    • A61M2025/0002—Catheters; Hollow probes for pressure measurement with a pressure sensor at the distal end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3344—Measuring or controlling pressure at the body treatment site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3351—Controlling upstream pump pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3355—Controlling downstream pump pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system
    • A61M2210/122—Pericardium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)

Abstract

Système et procédé d'oxygénation de tissu ischémique. L'invention concerne notamment un système et un procédé d'alimentation en oxygène du myocarde du c÷ur par l'intermédiaire de moyens autres que les artères coronaires. Le système de l'invention comprend un cathéter pouvant être utilisé pour injecter des solutions porteuses préoxygénées, telles que des émulsions de perfluorocarbure, ditrectement dans l'espace péricardique, c'est-à-dire l'espace situé entre le péricarde et la surface de l'épicarde. Les solutions préoxygénées peuvent être périodiquement ou continûment éliminées, et des solutions neuves peuvent être ensuite injectées dans l'espace péricardique.
PCT/US1991/009349 1990-12-14 1991-12-13 Systeme et procede d'oxygenation du c×ur utilisant des liquides sous-pericardiques Ceased WO1992010221A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP92903781A EP0515676B1 (fr) 1990-12-14 1991-12-13 Systeme d'oxygenation du c ur utilisant des liquides sous-pericardiques
DE69125152T DE69125152T2 (de) 1990-12-14 1991-12-13 System für die oxygenation des herzens unter verwendung von annähernd perikardialen flüssigkeiten
CA002076009A CA2076009C (fr) 1990-12-14 1991-12-13 Systeme et methode d'oxygenation du coeur au moyen de liquides subpericardiques

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US627,178 1990-12-14
US07/627,178 US5213570A (en) 1990-12-14 1990-12-14 System and method for oxygenation of the pericardium
US684,421 1991-04-12
US07/684,421 US5137510A (en) 1990-12-14 1991-04-12 System and method for oxygenation of the heart using subpericardial fluids

Publications (2)

Publication Number Publication Date
WO1992010221A2 WO1992010221A2 (fr) 1992-06-25
WO1992010221A3 true WO1992010221A3 (fr) 1992-09-03

Family

ID=27090360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/009349 Ceased WO1992010221A2 (fr) 1990-12-14 1991-12-13 Systeme et procede d'oxygenation du c×ur utilisant des liquides sous-pericardiques

Country Status (8)

Country Link
US (1) US5137510A (fr)
EP (1) EP0515676B1 (fr)
JP (1) JP3058284B2 (fr)
AT (1) ATE149845T1 (fr)
AU (1) AU642840B2 (fr)
CA (1) CA2076009C (fr)
DE (1) DE69125152T2 (fr)
WO (1) WO1992010221A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5269326A (en) * 1991-10-24 1993-12-14 Georgetown University Method for transvenously accessing the pericardial space via the right auricle for medical procedures
US5590651A (en) * 1995-01-17 1997-01-07 Temple University - Of The Commonwealth System Of Higher Education Breathable liquid elimination analysis
US5741248A (en) * 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
EP1264601A3 (fr) * 1995-11-01 2003-11-12 Chiron Corporation Traitement des affections coronariennes par introduction d'un agent therapeutique dans l'espace pericardique
WO1997016169A1 (fr) * 1995-11-01 1997-05-09 Chiron Corporation Traitement d'une indication cardiovasculaire par administration de substances therapeutiques dans l'espace pericardique
US5843024A (en) * 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
US5968010A (en) * 1997-04-30 1999-10-19 Beth Israel Deaconess Medical Center, Inc. Method for transvenously accessing the pericardial space via the right atrium
US6200303B1 (en) 1997-04-30 2001-03-13 Beth Israel Deaconess Medical Center, Inc. Method and kit for transvenously accessing the pericardial space via the right atrium
US20040215168A1 (en) * 1997-04-30 2004-10-28 Beth Israel Deaconess Medical Center Kit for transvenously accessing the pericardial space via the right atrium
US6679859B1 (en) 1997-10-24 2004-01-20 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
WO1999021541A2 (fr) * 1997-10-24 1999-05-06 Alliance Pharmaceutical Corp. Traitement des lesions ischemiques par des transporteurs d'oxygene synthetiques
US6302863B1 (en) * 1998-06-16 2001-10-16 Nikolai Tankovich Method for removal of lipids via a perfluorocarbon tumescent solution
US20030166550A1 (en) * 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US6440934B1 (en) 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US20020072489A1 (en) * 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法
US6932811B2 (en) * 2000-04-27 2005-08-23 Atricure, Inc. Transmural ablation device with integral EKG sensor
US20020107514A1 (en) 2000-04-27 2002-08-08 Hooven Michael D. Transmural ablation device with parallel jaws
CN105828850B (zh) * 2013-12-13 2019-07-23 阿姆斯特丹大学学术医学中心 用于冲洗心包腔的系统
WO2024050123A1 (fr) * 2022-09-02 2024-03-07 Boundless Science Llc Dispositif d'oxygénation extracorporelle

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003005A1 (fr) * 1983-12-29 1985-07-18 Fiddian Green Richard G Dispositif d'oxygenation a membrane intraluminale
US5009636A (en) * 1989-12-06 1991-04-23 The Kendall Company Dual-lumen catheter apparatus and method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4981691A (en) * 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US4795423A (en) * 1980-04-14 1989-01-03 Thomas Jefferson University Oxygenated perfluorinated perfusion of the ocular globe to treat ischemic retinopathy
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4413989A (en) * 1980-09-08 1983-11-08 Angiomedics Corporation Expandable occlusion apparatus
US4448188A (en) * 1982-02-18 1984-05-15 Laserscope, Inc. Method for providing an oxygen bearing liquid to a blood vessel for the performance of a medical procedure
US4671287A (en) * 1983-12-29 1987-06-09 Fiddian Green Richard G Apparatus and method for sustaining vitality of organs of the gastrointestinal tract
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
DE3679469D1 (de) * 1985-07-16 1991-07-04 Univ Jefferson Geraet zur zerebralen katheterisierung.
US4902276A (en) * 1986-06-09 1990-02-20 The Regents Of The University Of California Apparatus and method for removing obstructions in bodily organs or cavities

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003005A1 (fr) * 1983-12-29 1985-07-18 Fiddian Green Richard G Dispositif d'oxygenation a membrane intraluminale
US5009636A (en) * 1989-12-06 1991-04-23 The Kendall Company Dual-lumen catheter apparatus and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Research in Experimental Medicine, vol. 182, 27 May 1983, Springer-Verlag, (Berlin, DE), K.M. SEDLARIK et al.: "Experimentelle Untersuchungen zur Frage der Einflussnahme auf ein akut ischämisches Myokard mittels Applikation von Sauerstoff in den perikardialen Raum", pages 177-181 *

Also Published As

Publication number Publication date
JP3058284B2 (ja) 2000-07-04
CA2076009A1 (fr) 1992-06-15
DE69125152D1 (de) 1997-04-17
CA2076009C (fr) 1999-08-31
DE69125152T2 (de) 1997-06-19
EP0515676A1 (fr) 1992-12-02
EP0515676B1 (fr) 1997-03-12
US5137510A (en) 1992-08-11
WO1992010221A2 (fr) 1992-06-25
AU9174191A (en) 1992-07-08
ATE149845T1 (de) 1997-03-15
AU642840B2 (en) 1993-10-28
JPH05505131A (ja) 1993-08-05

Similar Documents

Publication Publication Date Title
WO1992010221A3 (fr) Systeme et procede d'oxygenation du c×ur utilisant des liquides sous-pericardiques
ATE66814T1 (de) Verlaengertes lagern roter blutzellen.
WO2000033725A3 (fr) Cardiopathie ischemique : methodes et dispositif de traitement par perfusion myocardique transveineuse
ATE22803T1 (de) Verfahren zur herstellung eines lagerstabilen, vernetzten haemoglobinpraeparates mit hoher sauerstoff-transportkapazitaet, sowie das nach diesem verfahren hergestellte haemoglobinpraeparat.
EP0714677A3 (fr) Procédé et appareil de stabilisation du rythme ventriculaire d'un coeur pendant une fibrillation auriculaire
AU2161888A (en) Anti-acne composition
DE69630445D1 (de) Gerät zum behandeln von Herzstillständen
NO158538C (no) Triazol- og imidazolforbindelser som anvendes i preparater for bekjempelse av sopp eller regulering av plantevekst.
FI873626A7 (fi) Triatsoli- tai imidatsoliryhmän omaavat 2,5-dihydrofuraanin johdannaiset, valmistusmenetelmä ja käyttösieniä tuhoavana aineena.
IL86223A0 (en) Amperometric method for the quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide(nadh)in solution
NO920837L (no) Kontrastmidler.
WO2002005871A3 (fr) Dispositif et procede d'assistance cardiaque
曾義雄 Taxonomical study of oribatid mites from Taiwan (Acarina: Astigmata)(II)
WO1998010085A3 (fr) Therapie genique utile pour traiter l'insuffisance cardiaque globale
DE3887197D1 (de) Verfahren zur Herstellung von Glucosedehydrogenase aus Bacillus megaterium.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
Warnock Factors affecting sound transmission loss
De Wolf Does ventricular dysfunction occur during liver transplantation?
Andersson Efficient search trees.
Lerner Myocarditis and pericarditis.
Vedernikov et al. Arterial endothelium-derived relaxing factor (AEDRF) does not suppress papillary muscle or portal vein contractions
JPS5581812A (en) Suppository for remedying diabetes
HUANG et al. Myocardial cardioplegia by retrograde and intrograde during coronary artery bypass graft
SE9301324D0 (sv) New method of treatment
Sherani Class, kinship and ritual: Islam and the politics of change in Pakistan.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 2076009

Country of ref document: CA

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 1992903781

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992903781

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992903781

Country of ref document: EP